NO178096C - Fremgangsmåte for fremstilling av et transdermalt leveringssystem for en farmasöytisk aktiv forbindelse - Google Patents

Fremgangsmåte for fremstilling av et transdermalt leveringssystem for en farmasöytisk aktiv forbindelse

Info

Publication number: NO178096C
Authority: NO; Norway
Prior art keywords: transdermal delivery; preparation; delivery system; active compound; pharmaceutically active
Prior art date: 1987-06-12

Application number

NO882559A

Other languages

English (en)

Norwegian (no)

Other versions

NO882559L (no

NO882559D0 (no

NO178096B (no

Inventor

John Michael Pawelchak

James Ronald Lawter

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-12

Filing date

1988-06-10

Publication date

1996-01-24

1988-06-10 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1988-06-10 Publication of NO882559D0 publication Critical patent/NO882559D0/no

1988-12-13 Publication of NO882559L publication Critical patent/NO882559L/no

1995-10-16 Publication of NO178096B publication Critical patent/NO178096B/no

1996-01-24 Publication of NO178096C publication Critical patent/NO178096C/no

Links

150000001875 compounds Chemical class 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
230000037317 transdermal delivery Effects 0.000 title abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO882559A 1987-06-12 1988-06-10 Fremgangsmåte for fremstilling av et transdermalt leveringssystem for en farmasöytisk aktiv forbindelse NO178096C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6184287A	1987-06-12	1987-06-12

Publications (4)

Publication Number	Publication Date
NO882559D0 NO882559D0 (no)	1988-06-10
NO882559L NO882559L (no)	1988-12-13
NO178096B NO178096B (no)	1995-10-16
NO178096C true NO178096C (no)	1996-01-24

Family

ID=22038497

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO882559A NO178096C (no)	1987-06-12	1988-06-10	Fremgangsmåte for fremstilling av et transdermalt leveringssystem for en farmasöytisk aktiv forbindelse

Country Status (16)

Country	Link
EP (1)	EP0294601B1 (de)
JP (1)	JP2654092B2 (de)
KR (1)	KR970000506B1 (de)
AT (1)	ATE84714T1 (de)
AU (1)	AU609142B2 (de)
CA (1)	CA1305418C (de)
DE (1)	DE3877630T2 (de)
DK (1)	DK171746B1 (de)
ES (1)	ES2043719T3 (de)
GR (1)	GR3006938T3 (de)
IE (1)	IE62735B1 (de)
IL (1)	IL86334A (de)
NO (1)	NO178096C (de)
NZ (1)	NZ224891A (de)
PT (1)	PT87704B (de)
ZA (1)	ZA884186B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5045553A (en) *	1987-06-24	1991-09-03	Fujisawa Pharmaceutical Company, Ltd.	Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
US6075024A (en)	1991-11-27	2000-06-13	Sepracor Inc.	Methods for treating infection using optically pure (S)-lomefloxacin
US5476854A (en) *	1991-11-27	1995-12-19	Sepracor Inc.	Methods and compositions for treating bacterial infection using optically pure (R)-lomefloxacin
US5834496A (en) *	1991-12-02	1998-11-10	Sepracor, Inc.	Methods for treating hypertension using optically pure S(-) felodipine
EP0668759B1 (de) *	1992-11-09	2003-05-28	Neurogesx, Inc.	Transdermale verabreichung von ketorolac
ES2375105T3 (es)	2001-06-18	2012-02-24	Noven Pharmaceuticals, Inc.	Administración mejorada de medicamentos en los sistemas transdérmicos.
WO2004110354A2 (en)	2003-05-15	2004-12-23	Roskamp Research, Llc	Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis
ES2449594T3 (es)	2007-10-05	2014-03-20	Alzheimer's Institute Of America, Inc.	Método para reducir deposición amiloide, neurotoxicidad amiloide y microgliosis con enantiomero (-)-nilvadipina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4284634A (en) *	1975-07-02	1981-08-18	Fujisawa Pharmaceutical Co., Ltd.	1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
US4338322A (en) *	1975-07-02	1982-07-06	Fujisawa Pharmaceutical Co., Ltd.	1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
CA1117117A (en) *	1978-10-10	1982-01-26	Fujisawa Pharmaceutical Co., Ltd.	2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
JPS6016917A (ja) *	1983-07-08	1985-01-28	Yamanouchi Pharmaceut Co Ltd	塩酸ニカルジピンまたはニフエジピンの軟膏剤
DE3419128A1 (de) *	1984-05-23	1985-11-28	Bayer Ag, 5090 Leverkusen	Dihydropyridinpraeparate und verfahren zu ihrer herstellung

1988
- 1988-05-10 EP EP88107473A patent/EP0294601B1/de not_active Expired - Lifetime
- 1988-05-10 DE DE8888107473T patent/DE3877630T2/de not_active Expired - Lifetime
- 1988-05-10 ES ES88107473T patent/ES2043719T3/es not_active Expired - Lifetime
- 1988-05-10 AT AT88107473T patent/ATE84714T1/de not_active IP Right Cessation
- 1988-05-11 IL IL86334A patent/IL86334A/xx not_active IP Right Cessation
- 1988-06-03 NZ NZ224891A patent/NZ224891A/en unknown
- 1988-06-09 PT PT87704A patent/PT87704B/pt not_active IP Right Cessation
- 1988-06-10 CA CA000569154A patent/CA1305418C/en not_active Expired - Lifetime
- 1988-06-10 DK DK316788A patent/DK171746B1/da not_active IP Right Cessation
- 1988-06-10 NO NO882559A patent/NO178096C/no not_active IP Right Cessation
- 1988-06-10 AU AU17610/88A patent/AU609142B2/en not_active Expired
- 1988-06-10 JP JP63141872A patent/JP2654092B2/ja not_active Expired - Fee Related
- 1988-06-10 IE IE174988A patent/IE62735B1/en not_active IP Right Cessation
- 1988-06-10 ZA ZA884186A patent/ZA884186B/xx unknown
- 1988-06-11 KR KR1019880007020A patent/KR970000506B1/ko not_active Expired - Fee Related
1993
- 1993-01-29 GR GR920402265T patent/GR3006938T3/el unknown

Also Published As

Publication number	Publication date
DK316788A (da)	1988-12-13
NO882559L (no)	1988-12-13
JPS6413024A (en)	1989-01-17
IL86334A (en)	1992-09-06
PT87704B (pt)	1993-03-31
GR3006938T3 (de)	1993-06-30
EP0294601A2 (de)	1988-12-14
IE62735B1 (en)	1995-02-22
CA1305418C (en)	1992-07-21
DE3877630D1 (de)	1993-03-04
KR890000090A (ko)	1989-03-11
IE881749L (en)	1988-12-12
AU609142B2 (en)	1991-04-26
ZA884186B (en)	1989-03-29
ATE84714T1 (de)	1993-02-15
NO882559D0 (no)	1988-06-10
AU1761088A (en)	1988-12-15
EP0294601A3 (en)	1989-10-11
JP2654092B2 (ja)	1997-09-17
NO178096B (no)	1995-10-16
DE3877630T2 (de)	1993-06-03
DK171746B1 (da)	1997-05-05
EP0294601B1 (de)	1993-01-20
PT87704A (pt)	1988-07-01
ES2043719T3 (es)	1994-01-01
NZ224891A (en)	1992-06-25
KR970000506B1 (ko)	1997-01-13
DK316788D0 (da)	1988-06-10

Similar Documents

Publication	Publication Date	Title
NO171787C (no)	1993-05-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-azabicyclo(3.2.1)oct-2-en-forbindelser
FI920601A0 (fi)	1992-02-12	Tvaofasig anordning foer transdermal dosering av laekemedel.
NO872946D0 (no)	1987-07-15	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO171853C (no)	1993-05-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive 7beta-(2-(tiazol-4-yl)-2-alkoksyiminoacetamido)-3-((1-pyrazolio)metyl)-3-cefem-4-karboksylat-forbindelser
NO165397C (no)	1991-02-06	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
FI901096A0 (fi)	1990-03-02	Menetelmä farmakologisesti aktiivisten /3-(C16-C18)alkaanisulfinyyli- ja -sulfonyyli-2-metoksimetyylipropyyli/-(2-trimetyyliammonio-etyyli)fosfaattien valmistamiseksi
NO178096C (no)	1996-01-24	Fremgangsmåte for fremstilling av et transdermalt leveringssystem for en farmasöytisk aktiv forbindelse
DK376188D0 (da)	1988-07-06	Farmaceutisk dosisenhed
NO885598L (no)	1989-06-20	Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser.
FI93444B (fi)	1994-12-30	Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
NO169963C (no)	1992-08-26	Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
EP0328634A4 (en)	1991-08-21	Pharmaceutical compositions for the treatment of psoriasis
IT1223343B (it)	1990-09-19	Formulazioni farmaceutiche per somministrazione transdermica
FI893163A0 (fi)	1989-06-28	Menetelmä 19-hydroksylaasi-inhibiittoreina käyttökelpoisten 19-substituoitujen progesteronijohdannaisten valmistamiseksi
NO171211C (no)	1993-02-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
NO168530C (no)	1992-03-04	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO911237D0 (no)	1991-03-26	Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og -kinolizidiner.
IL96506A0 (en)	1991-08-16	Transdermal system for administering pharmaceutical compounds under ph control
NO167381C (no)	1991-10-30	Analogifremgangsmaate for fremstilling av terapeutisk aktiv (e)-2-(p-fluorfenethyl)-3-fluorallylamin.
NO163327C (no)	1990-05-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.
NO892469L (no)	1989-12-18	Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-forbindelser.
DE3466877D1 (en)	1987-11-26	Crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
NO912745L (no)	1989-05-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,5,6-tetrahydropyridinforbindelser.
NO912746L (no)	1989-05-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidinforbindelser.

Legal Events

Date	Code	Title	Description
2008-06-23	MK1K	Patent expired